Cargando…

Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia

BACKGROUND: Controlling the false discovery rate is important when testing multiple hypotheses. To enhance the detection capability of a false discovery rate control test, we applied the likelihood ratio-based multiple testing method in neuroimage data and compared the performance with the existing...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Donghwan, Kang, Hyejin, Kim, Eunkyung, Lee, Hyekyoung, Kim, Heejung, Kim, Yu Kyeong, Lee, Youngjo, Lee, Dong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417288/
https://www.ncbi.nlm.nih.gov/pubmed/25633500
http://dx.doi.org/10.1186/1471-2288-15-9
_version_ 1782369349393186816
author Lee, Donghwan
Kang, Hyejin
Kim, Eunkyung
Lee, Hyekyoung
Kim, Heejung
Kim, Yu Kyeong
Lee, Youngjo
Lee, Dong Soo
author_facet Lee, Donghwan
Kang, Hyejin
Kim, Eunkyung
Lee, Hyekyoung
Kim, Heejung
Kim, Yu Kyeong
Lee, Youngjo
Lee, Dong Soo
author_sort Lee, Donghwan
collection PubMed
description BACKGROUND: Controlling the false discovery rate is important when testing multiple hypotheses. To enhance the detection capability of a false discovery rate control test, we applied the likelihood ratio-based multiple testing method in neuroimage data and compared the performance with the existing methods. METHODS: We analysed the performance of the likelihood ratio-based false discovery rate method using simulation data generated under independent assumption, and positron emission tomography data of Alzheimer’s disease and questionable dementia. We investigated how well the method detects extensive hypometabolic regions and compared the results to those of the conventional Benjamini Hochberg-false discovery rate method. RESULTS: Our findings show that the likelihood ratio-based false discovery rate method can control the false discovery rate, giving the smallest false non-discovery rate (for a one-sided test) or the smallest expected number of false assignments (for a two-sided test). Even though we assumed independence among voxels, the likelihood ratio-based false discovery rate method detected more extensive hypometabolic regions in 22 patients with Alzheimer’s disease, as compared to the 44 normal controls, than did the Benjamini Hochberg-false discovery rate method. The contingency and distribution patterns were consistent with those of previous studies. In 24 questionable dementia patients, the proposed likelihood ratio-based false discovery rate method was able to detect hypometabolism in the medial temporal region. CONCLUSIONS: This study showed that the proposed likelihood ratio-based false discovery rate method efficiently identifies extensive hypometabolic regions owing to its increased detection capability and ability to control the false discovery rate.
format Online
Article
Text
id pubmed-4417288
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44172882015-05-03 Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia Lee, Donghwan Kang, Hyejin Kim, Eunkyung Lee, Hyekyoung Kim, Heejung Kim, Yu Kyeong Lee, Youngjo Lee, Dong Soo BMC Med Res Methodol Research Article BACKGROUND: Controlling the false discovery rate is important when testing multiple hypotheses. To enhance the detection capability of a false discovery rate control test, we applied the likelihood ratio-based multiple testing method in neuroimage data and compared the performance with the existing methods. METHODS: We analysed the performance of the likelihood ratio-based false discovery rate method using simulation data generated under independent assumption, and positron emission tomography data of Alzheimer’s disease and questionable dementia. We investigated how well the method detects extensive hypometabolic regions and compared the results to those of the conventional Benjamini Hochberg-false discovery rate method. RESULTS: Our findings show that the likelihood ratio-based false discovery rate method can control the false discovery rate, giving the smallest false non-discovery rate (for a one-sided test) or the smallest expected number of false assignments (for a two-sided test). Even though we assumed independence among voxels, the likelihood ratio-based false discovery rate method detected more extensive hypometabolic regions in 22 patients with Alzheimer’s disease, as compared to the 44 normal controls, than did the Benjamini Hochberg-false discovery rate method. The contingency and distribution patterns were consistent with those of previous studies. In 24 questionable dementia patients, the proposed likelihood ratio-based false discovery rate method was able to detect hypometabolism in the medial temporal region. CONCLUSIONS: This study showed that the proposed likelihood ratio-based false discovery rate method efficiently identifies extensive hypometabolic regions owing to its increased detection capability and ability to control the false discovery rate. BioMed Central 2015-01-30 /pmc/articles/PMC4417288/ /pubmed/25633500 http://dx.doi.org/10.1186/1471-2288-15-9 Text en © Lee et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Lee, Donghwan
Kang, Hyejin
Kim, Eunkyung
Lee, Hyekyoung
Kim, Heejung
Kim, Yu Kyeong
Lee, Youngjo
Lee, Dong Soo
Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia
title Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia
title_full Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia
title_fullStr Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia
title_full_unstemmed Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia
title_short Optimal likelihood-ratio multiple testing with application to Alzheimer’s disease and questionable dementia
title_sort optimal likelihood-ratio multiple testing with application to alzheimer’s disease and questionable dementia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417288/
https://www.ncbi.nlm.nih.gov/pubmed/25633500
http://dx.doi.org/10.1186/1471-2288-15-9
work_keys_str_mv AT leedonghwan optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia
AT kanghyejin optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia
AT kimeunkyung optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia
AT leehyekyoung optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia
AT kimheejung optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia
AT kimyukyeong optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia
AT leeyoungjo optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia
AT leedongsoo optimallikelihoodratiomultipletestingwithapplicationtoalzheimersdiseaseandquestionabledementia